Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation.

Tomonari, A; Takahashi, S; Ooi, J; Tsukada, N; Konuma, T; Kobayashi, T; Takasugi, K; Iseki, T; Tojo, A; Asano, S

Tomonari, A; Takahashi, S; Ooi, J; Tsukada, N; Konuma, T; Kobayashi, T; Takasugi, K; Iseki, T; Tojo, A; Asano, S.

Affiliation

Tomonari A; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. atomonar@ims.u-tokyo.ac.jp

Bone Marrow Transplant ; 41(4): 371-6, 2008 Feb.

Article in En | MEDLINE | ID: mdl-17982495

Subject(s)

Antiviral Agents/administration & dosage; Cord Blood Stem Cell Transplantation/adverse effects; Cytomegalovirus Infections/prevention & control; Ganciclovir/administration & dosage; Adolescent; Adult; Case-Control Studies; Cytomegalovirus Infections/drug therapy; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pilot Projects

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Antiviral Agents / Ganciclovir / Cytomegalovirus Infections / Cord Blood Stem Cell Transplantation Type of study: Observational_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2008 Type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links